|
2-Day Program
April 23–24, 2020
|
|
Thursday, April 23, 2020
|
|
7–8 a.m.
|
Registration and Breakfast |
| 8 a.m. |
Opening Remarks
Samir M. Hanash, MD, PhD – The University of Texas MD Anderson Cancer Center |
|
Session I: “Omics” Technologies and the Surfaceome
|
|
Time:
|
8:20–10:20 a.m. |
|
8:20 a.m.
|
A Genetic Approach to Display and Dissect the Cancer-Associated Truncated O-Glycoprotein Epitome
Henrik Clausen, DDS, DSc – University of Copenhagen
|
|
8:50 a.m.
|
Developing EAGLE to Break the Tumor Glyco-Code
Li Peng, PhD – Palleon Pharmaceuticals
|
|
9:20 a.m.
|
RNA Seq Predicted Surfaceome
Helio Pais, PhD – Trivago
|
|
9:50 a.m.
|
Neoantigen Discovery and Targeting
John Castle, PhD – Agenus Inc.
|
|
10:20 a.m.
|
Break
|
|
Session II: Tumor Neoantigens
|
|
Time:
|
10:35 a.m.–12:35 p.m.
|
|
10:35 a.m.
|
Canonical Neoantigens
Beatriz M. Carreno, PhD – University of Pennsylvania
|
|
11:05 a.m.
|
Non-Canonical Tumor-Specific Antigens
Claude Perreault, MD – University of Montreal
|
|
11:35 a.m.
|
Manipulating Antigen Presentation by Serine Proteases
Jeffrey J. Molldrem, MD –The University of Texas MD Anderson Cancer Center
|
|
12:05 p.m.
|
RNA Edited Neoantigens
Patrick Hwu, MD – The University of Texas MD Anderson Cancer Center
|
|
Lunch
|
|
Time:
|
12:35–1:30 p.m.
|
|
Oral Abstract Presentations
|
|
Time:
|
1:30–2 p.m.
|
|
1:30 p.m.
|
Abstract Presentation
|
|
1:45 p.m.
|
Abstract Presentation
|
|
Keynote
|
|
Time:
|
2–3 p.m.
|
|
2 p.m.
|
Keynote Presentation
Carl H. June, MD – University of Pennsylvania
|
Session III: Extracellular Vesicles |
|
Time:
|
3–4 p.m.
|
|
3 p.m.
|
Exosomes as T cell Decoys
Samir M. Hanash, MD, PhD – The University of Texas MD Anderson Cancer Center
|
|
3:30 p.m.
|
The Immunopeptidome of Exosomes
Simon J. Powis, PhD – University of St. Andrews
|
|
4 p.m.
|
Break
|
Session IV: Post-translational Modifications |
|
Time:
|
4:20–5:50 p.m.
|
|
4:20 p.m.
|
Peptide Analysis
Donald F. Hunt, PhD – University of Virginia
|
|
4:50 p.m.
|
Discovery of Cancer-specific Aberrant O-Glycopeptide Epitopes
Catharina Steentoft, PhD – University of Copenhagen
|
|
5:20 p.m.
|
Tumor-specific Glycosylation and Antibody-Based Targeting
Richard D. Cummings, PhD – Harvard Medical School
|
| 5:50 p.m. |
Closing Remarks
Samir M. Hanash, MD, PhD – The University of Texas MD Anderson Cancer Center |
|
Poster Reception
|
|
Time:
|
6–7 p.m.
|
|
6 p.m.
|
Poster Reception
|
|
7 p.m.
|
Adjourn
|